Background: Alcohol (ALC) causes suppressed secretion of prepubertal luteinizing hormone-releasing hormone (LHRH). Insulin-like growth factor-1 (IGF-1) and kisspeptin (Kp) are major regulators of LHRH and are critical for puberty. IGF-1 may be an upstream mediator of Kp in the preoptic area and rostral hypothalamic area (POA/RHA) of the rat brain, a region containing both Kp and LHRH neurons. We investigated the ability of IGF-1 to stimulate prepubertal Kp synthesis and release in POA/RHA, and the potential inhibitory effects of ALC.
T HE ONSET OF puberty is the result of an increase in the synthesis and secretion of luteinizing hormonereleasing hormone (LHRH). This is due to a series of complex interactions within the preoptic/hypothalamic region of the brain in which there is the gradual removal of prepubertal inhibitory influences (Terasawa, 1999; Terasawa and Fernandez, 2001) , along with the development of enhanced excitatory influences (Claypool et al., 2000; Dearth et al., 2000; Hiney et al., 1991 Hiney et al., , 1996 Navarro et al., 2004a; Ojeda et al., 1990; Sarkar et al., 1981; Thompson et al., 2004; Urbanski and Ojeda, 1990) . Among the excitatory influences, both insulin-like growth factor-1 (IGF-1) and the kisspeptins, the latter being peptide products of the KiSS-1 gene, are considered pivotal in the upstream control of LHRH synthesis and secretion at puberty (Hiney et al., 1996; Keen et al., 2008; Navarro et al., 2004a,b; Shahab et al., 2005; Wilson, 1998) . Thus, gaining a better understanding of the actions and potential interactions between these 2 peptides with regard to the control of LHRH could provide important information about critical events leading to the onset of puberty. In this regard, the IGF-1 peptide has been shown to up-regulate prepubertal KiSS-1 gene expression in the preoptic area and rostral hypothalamic area (POA/RHA) of the rat brain, a region that includes the anteroventral periventricular (AVPV) nucleus ). More recently, research has shown that kisspeptin (Kp) synthesis is mediated by an Akt/mammalian target of rapamycin (mTOR) pathway (Srivastava et al., 2016) . It is noteworthy that IGF-1 normally increases as puberty approaches and that Akt is a transduction signal that is involved in mediating some of the effects of IGF-1 (Cardona-Gomez et al., 2002) . Furthermore, Kp-producing neurons in the AVPV nucleus project to LHRH-synthesizing neurons in the POA/RHA that express Kp receptors (Han et al., 2005; Parhar et al., 2004; Yeo and Herbison, 2011) . Taken together, this information provides evidence suggesting important interactions between IGF-1, Kp, and LHRH.
Defining the interactions between IGF-1 and Kp is not only important for discerning normal pubertal events, but also provides avenues for determining mechanisms by which neuroendocrine-disrupting substances, such as alcohol (ALC), can alter LHRH and the pubertal process. Prepubertal ALC exposure has been shown to act at the hypothalamic level to suppress the release of LHRH Dissen et al., 2004) resulting in delayed pubertal events in rats (Bo et al., 1982; Emanuele et al., 2002) , rhesus monkeys , and adolescent girls (Peck et al., 2011; Richards and Oinonen, 2011) . In recent years, we have investigated the influences of ALC on both IGF-1 and the KiSS-1/Kp system with regard to LHRH synthesis and release at puberty. In this regard, it is well documented that prepubertal ALC administration causes suppressed circulating levels of IGF-1 in female rats (Emanuele et al., 2002; Srivastava et al., 1995) and rhesus monkeys ; thus, suppressing the amount of the peptide available to the hypothalamus. Importantly, ALC acts within the hypothalamus to inhibit IGF-1-induced LHRH/luteinizing hormone (LH) release (Hiney et al., 1998) . Also, both chronic ) and acute (Hiney et al., 2010 ) ALC administrations cause suppressed basal KiSS-1 gene expression in the prepubertal female hypothalamus. Thus, while progress has been made, more attention is needed to define the sites and mechanisms of the actions and interactions between IGF-1 and ALC regarding physiological control of the prepubertal KiSS-1/Kp system, a critical regulator of LHRH synthesis and secretion at the time of puberty.
MATERIALS AND METHODS

Animals for In Vivo Study
Eighteen-day pregnant female rats of the Sprague-Dawley line were purchased from Charles River (Boston, MA) and allowed to deliver pups normally in the Texas A&M University laboratory animal facility. Female pups were weaned at 21 days of age and housed 3 per cage (Allentown NexGen individually ventilated caging system; Houston, TX) under controlled conditions of light (lights on, 0600 hours; lights off, 1800 hours) and temperature (23°C), with ad libitum access to food (Teklad Global 16% Protein rodent diet; Envigo, Houston, TX) and water. All procedures performed on the animals were approved by the University Animal Care and Use Committee and in accordance with the NAS-NRC Guidelines for the Care and Use of Laboratory Animals. Surgical anesthesia was an intraperitoneal injection of 2.5% tribromoethanol (0.5 ml/60 g body weight).
Assessment of Kp Protein Synthesis
Twenty-two-day-old female rats were implanted with third ventricular (3V) cannulae as described previously . After 4 days of recovery, half of the rats were administered water (control group) and the other half received a dose of ALC (3 g/kg; 1.5 ml 25% ethanol [EtOH]/100 g rat) by gastric gavage at 0730 hours. This dose of ALC was chosen because a single intragastric injection to immature female rats yields a moderate blood ALC level and is capable of consistently suppressing LH release (Hiney et al., 1998 (Hiney et al., , 2003 . The animals were undisturbed for 90 minutes to allow time for EtOH absorption. The ALC and control groups were then subdivided such that half of the rats in each group were injected with IGF-1 (rat IGF-1; ProSpec, Rehovot, Israel, 200 ng/ 3 ll) and the other half received an equal volume of saline into the 3V at 0900 hours. A second dose of ALC (2 g/kg) or water was administered gastrically at 1130 hours (4 hours after the first dose) to maintain a moderately elevated serum EtOH level over the course of the 6 hours after the IGF-1 injection. This overall protocol was repeated several times to complete the study, and each replica experiment always contained control and IGF-1-only groups, and the ALC dose with and without IGF-1. All animals were killed at 1500 hours, 6 hours after the 3V injection of IGF-1 or saline. The IGF-1 dose and 6-hour time point were chosen based on our recent dose-response study demonstrating IGF-1 induction of KiSS-1 gene transcription ). The brains were removed, 3V placement was verified, and blocks of tissue containing the POA/RHA were dissected from the brain as described previously ). This brain region was chosen because, in the rat, populations of both Kp-and LHRH-producing neurons are present, most of the LHRH neurons express the Kp receptors (Han et al., 2005; Messager et al., 2005; Parhar et al., 2004) , and IGF-1 has been shown to stimulate KiSS-1 gene expression in this area ). The medial basal hypothalamus was not assessed because IGF-1 does not stimulate the KiSS-1 gene in this region and because this area does not contain the LHRH neurons in the rat (Kozlowski and Dees, 1984) , only the nerve terminals. After tissue collection, the samples were frozen on dry ice for protein assessments by Western blot analysis. Trunk blood was collected at that time for subsequent measurement of blood ALC concentrations by an enzymatic method using a diagnostic kit purchase from BioAssay Systems (Hayward, CA).
Western Blot Analysis
Brain tissues were homogenized in 1% IGEPAL CA-630, 20 mM Tris-Cl, pH (8.0), 137 mM NaCl, 2 mM EDTA, 10% glycerol, 10 mM sodium pyruvate, 10 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, and 0.25% protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) at 4°C. The homogenates were incubated on ice for 30 minutes and centrifuged at 12,0009g for 15 minutes. The concentration of total protein in the resulting supernatant was determined by the Pierce 660 nm Protein assay kit (Thermo Scientific, Rockford, IL) using bovine serum albumin as standard. Immunoblot analysis was performed by solubilizing the proteins (100 lg) in a sample buffer containing 62.5 mM Tris-Cl, pH 6.8, 2% SDS, 5% b-mercaptoethanol, 10% glycerol, and 0.02% bromophenol blue and electrophoresed through 4 to 20% SDS-PAGE for insulin receptor substrate 1 (IRS-1), proline-rich Akt substrate of 40 kDa (PRAS40), Akt, tuberous sclerosis 2 (TSC2), ras homologue enriched in brain (Rheb), mTOR, and Kp under reducing conditions. The separated proteins were electrophoretically transblotted onto polyvinylidene difluoride membranes. Following transfer, membranes were blocked with 5% nonfat dried milk/0.1% Tween-20 in phosphate buffered saline (PBS) (pH 7.4) for 3 hours and subsequently incubated at 4°C overnight with rabbit anti-total-IRS-1 (1:500; Cohesion Biosciences Ltd, London, UK) or anti-p-IRS-1 (Ser307; 1:500; Assay Biotechnology Company, Inc., Sunnyvale, CA), rabbit anti-total (1:1,000)-or antip-Akt (Ser473, 1:3,000; Cell Signaling Tech., Danvers, MA), rabbit anti-total (1:2,000)-or anti-p-TSC2 (Thr1462, 1:250; Cell Signaling Tech.), rabbit anti-Rheb (1 lg/ml; Abcam Inc., Cambridge, MA), rabbit anti-total-or anti-p-mTOR (Ser2448, 1:1,000; Cell Signaling Tech.), and rabbit anti-Kp (3 lg/ml; Novus Biologicals, Littleton, CO). The specificity of each primary antibody was checked by preabsorbing with an excess (4-to 5-fold) of the specific protein/peptide being tested and incubating at 23°C for 3 hours. After the incubation, membranes were washed in PBS/0.1% Tween-20 and then incubated with horseradish peroxidase-labeled goat anti-rabbit IgG (1:50,000; Santa Cruz Biotech., Santa Cruz, CA) for 2 hours at room temperature. Following washing, the specific signals were detected with the enhanced chemiluminescence (Western Lightning Plus-ECL; PerkinElmer, Shelton, CT) and quantified with NIH ImageJ software version 1.43 (National Institutes of Health, Bethesda, MD). Subsequently, all membranes were also stripped using ReBlot Plus kit (EMD Millipore, Temecula, CA) and reprobed with mouse monoclonal antibody to ß-actin and goat anti-mouse secondary antibody, to normalize for the amount of sample loading when appropriate. Following washing, the detection and quantitation of b-actin were conducted as described above.
Animals for Assessing IGF-1-Induced Kp Release In Vitro POA/RHA tissues were collected from animals killed either during late juvenile development or during first proestrus. Tissues from the juvenile animals were collected from 28-to 32-day-old rats prior to the animals entering the peripubertal phase of development. To obtain sufficient numbers of proestrous tissues at 1 time, we administered pregnant mare serum gonadotropin (15 IU/0.1 ml saline; Bioworld, Dublin, OH) to 32-day-old rats to stimulate estradiol (E 2 ) secretion by the ovaries and induce first proestrus. The tissues were collected from these animals 48 hours later. The rats were confirmed to be in these phases of puberty by criteria we have previously described . Briefly, all juvenile animals had small uteri (less than 150 mg) with no intraluminal fluid content and closed vaginae. Animals in the late proestrous phase of the peripubertal period were selected and had large uteri (over 300 mg) with a substantial amount of intraluminal fluid and usually closed vaginae. As some rats show an open vagina at the time of first proestrus, vaginal smears were performed on those animals and the presence of a typical proestrous cytology was confirmed.
Effect of ALC on IGF-1-Induced Kp Release In Vitro
Prepubertal female rats were decapitated, and the POA/RHA fragments, which include the AVPV nucleus, were dissected under a stereomicroscope as previously described . Briefly, each tissue block was incubated in Locke's buffer (2 mM HEPES, 154 mM NaCl, 5.6 mM KCl, 1 mM MgCl 2 , 6 mM NaHCO 3 , 10 mM glucose, and 1.25 mM CaCl 2 , pH 7.4) inside a Dubnoff shaker (95 cycles/min) at 37°C in an atmosphere of 95% O 2 and 5% CO 2 . After a 30-minute equilibration period, the medium was discarded and replaced with fresh medium for 30 minutes to establish basal release. Subsequently, these media were saved in microcentrifuge tubes and then replaced with medium containing IGF-1 (200 ng/ml). After a 30-minute incubation, the samples were collected and saved for subsequent assessment of Kp using a radioimmunoassay kit purchased from Phoenix Pharmaceuticals (Burlingame, CA). To verify that ALC blocks the IGF-1-induced Kp release, POA/RHA fragments were incubated as above with the following changes. Tissues were incubated for 60 minutes after the basal incubation in medium plus 50 mM ALC and then collected and incubated for an additional 30 minutes in medium with 50 mM ALC plus IGF-1. The 50 mM dose has an initial ALC content approximately equivalent to 220 to 230 mg/dL in blood and was chosen because it is the minimal effective dose of ALC that blocks IGF-1-induced LHRH release in vitro (Hiney et al., 1998 (Hiney et al., , 2003 . Following completion of all the experiments, POA/RHA fragments were weighed to nearest 0.1 mg.
Statistical Analysis
Student's t-test analyzed the differences between basal Kp secretion and IGF-1-stimulated Kp release in the in vitro experiments. Multiple comparisons were performed using analysis of variance with post hoc testing using the Student-Newman-Keuls multiplecomparison test between the 4 treatment groups analyzed by quantitation of the Western blots. These statistical tests were conducted with INSTAT software (GraphPad Software, San Diego, CA). Probability values less than 0.05 were considered significantly different.
RESULTS
IGF-1 and ALC Effects on Kp Synthesis
The mean (AESEM) blood ALC concentration 2 hours after the second ALC dose was 165 AE 10.2 mg/dL, similar to moderate levels attained in previous studies (Dees et al., 2005; Hiney et al., 2010) . Figure 1 shows that the central administration of IGF-1 to control animals induced an increase in Kp protein expression in the POA/RHA. The ALC-treated animals that received the 3V injection of saline did not reveal altered basal Kp expression, but the increase in Kp expression induced by the central delivery of IGF-1 was blocked by the presence of ALC. Although these novel effects of IGF-1 and ALC are important, it then became necessary to more completely delineate the signaling pathway utilized by IGF-1 within the POA/RHA and determine the site and mechanism by which ALC altered the IGF-1 induction of Kp.
As Akt is a transduction signal mediating some of the actions of IGF-1 (Cardona-Gomez et al., 2002) , including activation of mTOR (Srivastava et al., 2016) , a regulator of Kp (Roa et al., 2009 ), we used the same tissues as above to assess the effects of IGF-1 and ALC on an interactive pathway from Akt to mTOR. Figure 2 demonstrates that central delivery of IGF-1 to control animals stimulated an increase in the phosphorylation of the Akt (p-Akt) protein expression in the POA/RHA compared to those control animals that received saline. Furthermore, although ALC did not alter basal Akt or p-Akt expressions after the central delivery of saline, the drug blocked the central action of IGF-1 to induce p-Akt. Downstream from Akt, we showed that the central administration of IGF-1 to control animals also stimulated the phosphorylation of TSC2 compared to the controls that received the saline (Fig. 3A,B) . This action to phosphorylate TSC2 subsequently allowed for the increased expression observed in Rheb (Fig. 3C,D) , and therefore inducing the increased expression of mTOR protein (Fig. 4) . Figures 3 and 4 also show that the basal expressions of TSC2, Rheb, and mTOR proteins were not altered in the ALC-treated animals by the central delivery of saline, but that the ALC prevented the central delivery of IGF-1 from stimulating increased expressions of each of these proteins.
While the above reveals an IGF-1-induced Akt signaling pathway to mTOR, we could not rule out the possibility that an alternate pathway utilized by Akt to regulate mTOR was also activated by IGF-1. Therefore, we assessed whether IGF-1-activated Akt would alter PRAS40, the inhibitory subunit of the mTOR complex (Wang et al., 2012) . Our results indicate that neither the central delivery of IGF-1 to control animals (0.53 AE 0.04) nor ALC administration either without (0.55 AE 0.03) or with (0.51 AE 0.04) the administration of IGF-1 altered PRAS40 expression compared to the control animals that received saline centrally (0.48 AE 0.04).
To determine the site and mechanism by which ALC inhibits IGF-1-regulated mTOR and Kp synthesis, we assessed the effects of ALC upstream to Akt within the POA/RHA. The results showed that in control animals, the centrally delivered IGF-1 stimulated phosphorylation of the main substrate of the IGF-1 receptor (IGF-1R) and IRS-1 protein (Fig. 5) , thus confirming peptide activation of IGF-1R, and ultimately, the downstream increases in Akt, Rheb, mTOR, and Kp proteins shown above. Furthermore, Fig. 5 also demonstrates that basal expression of IRS-1 was not altered in the ALC-treated animals by the central delivery of saline; however, the ALC prevented the IGF-1 stimulation of IRS-1, indicating the site of the inhibitory effect of ALC was at the IGF-1R/IRS-1 complex.
IGF-1 and ALC Effects on Kp Release
To determine the ability of IGF-1 to stimulate Kp release, POA/RHA tissues from immature rats collected during juvenile and first proestrous phases of development were incubated in vitro. Results revealed that IGF-1 did not alter Kp secretion as compared to their basal levels from the tissues obtained from juvenile animals (basal: 1.32 AE 0.10 vs. IGF-1: 1.08 AE 0.11; N = 16). However, tissues obtained from animals during their first proestrus showed that IGF-1 (200 ng/ml) markedly increased (p < 0.001) the release of Kp when compared to their basal levels of secretion (Fig. 6A) . As expected, as IGF-1Rs are blocked by ALC, no IGF-1 stimulation was observed from the proestrous tissues when ALC (50 mM) was present in the medium (Fig. 6B) .
DISCUSSION
Prepubertal ALC consumption by young girls has been associated with delayed breast development (Peck et al., 2011) and the onset of menarche (Richards and Oinonen, 2011) . Also girls using ALC have a 4 times greater chance of showing signs of delayed puberty than nonusers (Peck et al., 2011) . Animal models show very similar results regarding ALC-induced delayed pubertal development. In rats, ALC caused a delay in vaginal opening and the age of first estrus Emanuele et al., 2002) , and in rhesus monkeys, ALC caused a delay in the development of a regular monthly pattern of menstruation . Animal studies also demonstrated that altered pubertal development resulting from ALC is due to an action within the hypothalamus to suppress LHRH synthesis and secretion and, therefore, its ability to stimulate the puberty-related pituitary and ovarian hormones involved in the developmental process (for review, see Dees et al., 2017) . Because LHRH is the driving force behind the onset of puberty, identifying factors that control its synthesis and secretion are important not only for addressing control of normal puberty, but also for assessing mechanisms by which ALC, for example, can alter its release and, hence, the progression of puberty.
Although several neuromodulators can affect LHRH secretion, IGF-1 and Kp are now considered pivotal upstream signaling components that contribute to regulation of LHRH and the timing of puberty (Hiney et al., 1991 (Hiney et al., , 1996 Keen et al., 2008; Navarro et al., 2004a,b; Shahab et al., 2005; Thompson et al., 2004; Wilson, 1998) . Importantly, centrally administered IGF-1 has been shown to up-regulate the KiSS-1 gene in the POA/RHA obtained from juvenile, anestrous animals with normally low levels of E 2 , thus suggesting an IGF-1 action and not that of E 2 . Furthermore, the stimulation of endogenous IGF-1 caused an increase in Kp protein expression in the same brain region (Srivastava et al., 2016) , thus suggesting IGF-1 is an upstream regulator of Kp synthesis. The ability of ALC to block the central action of IGF-1 to induce KiSS-1 gene expression (Hiney et al., 2010) prompted us to more closely investigate IGF-1-ALC interactions as they relate to the control of Kp and, ultimately, LHRH. Similar to the above study that showed IGF-1 induction of KiSS-1 gene expression, we now demonstrate that the direct central delivery of IGF-1 caused increased Kp protein expression in the POA/RHA of anestrous animals, an action that was blocked by ALC. To determine the upstream site of this action, we initially assessed the effect of ALC on a recently identified Akt-mediated pathway used by IGF-1 to induce Kp expression (Srivastava et al., 2016) . In this regard, we showed that ALC blocked the IGF-1-induced phosphorylation of Akt, an action that is in agreement with a previous study (Hiney et al., 2010) . Using the same tissues, we demonstrated here that downstream from Akt, the ALC suppressed phosphorylation of TSC2, Rheb, and finally, mTOR. This suppression of IGF-1-induced mTOR by ALC is important, as mTOR is a known regulator of KiSS-1/Kp (Roa et al., 2009 ) and, thus, LHRH neuronal activity.
To confirm the above pathway specificity, an alternate Akt pathway to mTOR was assessed. In this case, activation of PRAS40 would result in suppressed mTOR (Wang et al., 2012) . This possibility was eliminated as neither IGF-1 stimulation of Akt nor ALC alone affected basal PRAS40 expression. Thus, it is clear from these studies that while a specific IGF-1-induced transduction signaling pathway mediated by Akt was affected by ALC, the exact site and mechanism of this action to inhibit the IGF-1-induced Kp synthesis appeared to be upstream to Akt. Subsequent assessments upstream to Akt revealed that IGF-1 induced the phosphorylation of IRS-1 in the POA/RHA, thus confirming IGF-1 peptide activation of the IGF-1R. Importantly, ALC blocked this action, thereby demonstrating the inhibitory effect of ALC on the IGF-1R/IRS-1 complex.
Current evidence indicates that once Kp is released, it stimulates LHRH synthesis and secretion by a direct action on LHRH neuronal perikarya present in the POA/RHA. In this regard, Kp receptors are expressed on the majority of LHRH neurons localized in the POA/RHA of the rat brain (Han et al., 2005; Messager et al., 2005; Parhar et al., 2004) , and Kp nerve processes have been shown to be closely associated with these neurons (Clarkson and Herbison, 2006; Decourt et al., 2008; Smith et al., 2008) . The present results now demonstrate that while IGF-1 was not effective in inducing Kp release from POA/RHA explants removed from rats during late juvenile development, when E 2 levels are low, it was capable of stimulating the release of Kp from explants removed from rats in their first proestrus. This is important as Kp is a potent stimulator of LHRH/LH release during the proestrous phase of development (Clarkson and Herbison, 2009; Clarkson et al., 2010; Popa et al., 2008) , when E 2 levels are known to be rising toward the LHRH/LH surge. Furthermore, firing rates of Kp-producing neurons in the RHA are increased during proestrus (Ducret et al., 2010) , and at this time, Kp can directly depolarize and induce LHRH neuronal firing rates in vitro (Liu et al., 2008; Pielecka-Fortuna et al., 2008; Zhang et al., 2008) . Hence, the action we describe here with regard to IGF-1-stimulated Kp release during proestrus supports the fact that Kp neurons in the RHA region of the rodent brain play a pivotal role in relaying the positive feedback effect of rising E 2 to the LHRH neurons at this time of development (Terasawa et al., 1980; Wintermantel et al., 2006) . Thus, in addition to stimulating Kp synthesis, our results demonstrate a role for IGF-1 in controlling the prepubertal release of Kp and, therefore, ultimately contributing to the synthesis and release of LHRH as puberty approaches. Additionally, as described above regarding synthesis, the ability of IGF-1 to stimulate Kp release was also inhibited by the action of ALC to block the IGF-1R.
The results from this study demonstrate for the first time the ability of IGF-1 to stimulate prepubertal synthesis of the Kp protein, as well as its peripubertal release within the POA/RHA. The IGF-1 influence was due to the peptide activating an IGF-1R/Akt-mediated signaling pathway regulating Kp. Furthermore, we show that ALC acts at the level of the IGF-1R to block the downstream components of the pathway resulting in suppressed prepubertal Kp protein synthesis, and an inhibition in its release during first proestrus. Figure 7A represents a schematic drawing depicting the IGF-1-mediated pathway to Kp, and Fig. 7B reveals the upstream site of the ALC inhibition. Overall, these data show conclusively an important prepubertal interrelationship between IGF-1 and Kp and demonstrate the ability of ALC to alter this relationship causing suppressed Kp, a critical prepubertal regulator of LHRH. We suggest this action, at least in part, contributes to the ALC-induced suppression in LHRH and delayed puberty.
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